In Vitro Generation of Human NK Cells Expressing Chimeric Antigen Receptor Through Differentiation of Gene-Modified Hematopoietic Stem Cells

Methods in Molecular Biology - United States
doi 10.1007/978-1-4939-3684-7_20
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer New York

Related search

CML Hematopoietic Stem Cells Expressing IL-1RAP Can Be Targeted by Chimeric Antigen Receptor (CAR)-engineered T Cells

Cancer Research
Cancer ResearchOncology
2018English

Induced Pluripotent Stem (iPS) Cell–derived, Chimeric Antigen Receptor (CAR)-expressing T Cells for Immunotherapy

Science-Business eXchange
2013English

Chimeric Antigen Receptor Expressing Natural Killer Cells for the Immunotherapy of Cancer

Frontiers in Immunology
AllergyImmunology
2018English

Chimeric Antigen Receptor T-Cells

Cancer Journal
Cancer ResearchOncology
2015English

Conditional Negative Selection of Gene-Modified Hematopoietic Stem Cells

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2012English

Chimeric Antigen Receptor CAR NK Cells Emerging Immunotherapy for the Treatment of Cancer

2019English

You Have Got a Fast CAR: Chimeric Antigen Receptor NK Cells in Cancer Therapy

Cancers
Cancer ResearchOncology
2020English

Correction: In Vitro Pre-Clinical Validation of Suicide Gene Modified Anti-Cd33 Redirected Chimeric Antigen Receptor T-Cells for Acute Myeloid Leukemia

PLoS ONE
Multidisciplinary
2017English

Role of CD34 Antigen in Myeloid Differentiation of Human Hematopoietic Progenitor Cells

Stem Cells
MedicineMolecular MedicineDevelopmental BiologyCell Biology
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy